Notice

We use cookies to constantly improve our internet content and to create internal assessments pursuant to our data protection guidelines.

Further information

OK

LINC 2013 Programme

Find all topics and speakers listed below.

Discussion Forum

10 events
  • Wednesday, January 23rd: - , Discussion Forum

    Why I do what I do in SFA occlusive disease?

    Chairman:
    Peter Soukas
    Discussant:
    Gerrit Krupski-Berdien, Ulf Teichgräber
    1. -

      Introduction by the chairman

    2. -

      How do I treat de-novo lesions?

        Peter Soukas
    3. -

      What do most recent trials suggest?

        Gerrit Krupski-Berdien
    4. -

      When do I use BMS? Will new stent designs provide better results and value?

        Ulf Teichgräber
    5. -

      How do I treat in-stent restenosis in SFA?

    6. -

      Discussion and conclusion

  • Wednesday, January 23rd: - , Discussion Forum

    Management of acute stroke – What will bet he future?

    Chairman:
    Sumaira Macdonald, Horst Sievert
    Discussant:
    Gerhard Schroth, Nick Hopkins, Eberhard Wedell, Zoran Milosevic
    1. -

      Current status of stroke management – available infrastructure and therapies

        Horst Sievert
    2. -

      Is there a need for early interventional treatment?

        Gerhard Schroth
    3. -

      How to be successful in mechanical stroke management – tips and tricks

        Nick Hopkins
    4. -

      Overcoming the technical challenges – My personal experience with latest generation retriever systems for stroke therapy

        Eberhard Wedell
    5. -

      Permanent implantation stents in patients with acute ischemic stroke

        Zoran Milosevic
    6. -

      Roundtable Discussion: What will be the future of stroke therapy?

  • Thursday, January 24th: - , Discussion Forum

    VIVA @ LINC: The future of renal revascularization

    Chairman:
    Michael Jaff, Sean Lyden
    Discussant:
    Sean Lyden, Peter Soukas, Sumaira Macdonald, Chris Metzger, Krishna Rocha-Singh
    1. -

      Case presentation

  • Thursday, January 24th: - , Discussion Forum

    Is there an optimal treatment for in-stent-restonosis?

    Chairman:
    Krishna Rocha-Singh
    Discussant:
    Renu Virmani, Francesco Liistro, Sean Lyden, Martin Werner, Marc Bosiers
    1. -

      In-stent restenosis – Insights into the pathomechanism and what it takes to be successful

        Renu Virmani
    2. -

      Why DEBs are first choice therapy for ISR and how it actually works

        Francesco Liistro
    3. -

      Drug delivery without a scaffold? DES are the much more solid solution

        Sean Lyden
    4. -

      Endovascular radiation therapy is still the best

        Matthias Ulrich
    5. -

      Re-lining the whole stent with covered endoprostheses – the best solution for ISR?

        Marc Bosiers
    6. -

      Atherectomy/Laser + DEB: A safe and effective solution?

        Jos van den Berg
    7. -

      Discussion and conclusion

  • Thursday, January 24th: - , Discussion Forum

    The Great Debate: “Leaving nothing behind” – the new paradigm for peripheral interventions?

    Chairman:
    Marc Bosiers
    Discussant:
    Renu Virmani, Erich Minar, Giancarlo Biamino, Iris Baumgartner
    1. -

      What is worse: Metallic implants or toxic drugs?

        Renu Virmani
    2. -

      What is the benchmark? A review of clinical trial results on nitinol stents and DES

        Erich Minar
    3. -

      How good are DEBs? Insights from RCTs and real world practice with different DEB Technologies

        Giancarlo Biamino
    4. -

      DEB vs PTA vs BMS: results from a meta-analysis

        Massimiliano Fusaro
    5. -

      All what we don’t know about DEBs

        Iris Baumgartner
    6. -

      How cost effective is the concept of “leaving nothing behind”

    7. -

      Discussion and conclusion

  • Thursday, January 24th: - , Discussion Forum

    To treat or not to treat: open questions in endovascular grafting

    Chairman:
    Peter Taylor
    Discussant:
    Jan Brunkwall, Alan Lumsden, Santi Trimarchi, Mohammad Hamady
    1. -

      Is there an option to treat acute uncomplicated dissection by endovascular means?

        Jan Brunkwall
    2. -

      Discussion

    3. -

      Roughly 25% of acute uncomplicated dissections get complicated later are there indicators which allow to treat them early?

        Peter Taylor
    4. -

      Discussion

    5. -

      Minimizing emboli during endovascular theatment of the thoracic aorta possibilities and open questions

        Alan Lumsden
    6. -

      Discussion and conclusion by the chairman

  • Thursday, January 24th: - , Discussion Forum

    CX @ LINC: Carotid stenting or carotid endarterectomy

    Chairman:
    Roger Greenhalgh
    1. -

      Carotid stenting was good, is good and wins

        Sriram Iyer
    2. -

      Look at the SVS guidelines!

        Frank Veith
    3. -

      CREST puts stenting ahead

        William Gray
    4. -

      You must be joking!

        Michel Makaroun
    5. -

      Be reasonable – learn stenting properly!

        Peter Gaines
    6. -

      Whatever for?

        Peter Taylor
    7. -

      The half-way house may settle it

        Sumaira Macdonald
    8. -

      Say what you like, I am unconvinced!

        Frans Moll
    9. -

      Panel discussion and audience participation

  • Friday, January 25th: - , Discussion Forum

    VIVA @ LINC: Carotid disasters and near disasters

    Chairman:
    Peter Schneider
    Discussant:
    Sean Lyden, Gary Ansel, Michael Jaff, Nick Hopkins, William Gray
    1. -

      Case presentation

  • Friday, January 25th: - , Discussion Forum

    CX @ LINC: Controversies in lower limb ischaemia

    Chairman:
    Roger Greenhalgh
    1. -

      The crucial presenting symptom

        Roberto Ferraresi
    2. -

      The MIMICS trial principles

        Peter Gaines
    3. -

      Go for subintimal angioplasty whenever possible

        Amman Bolia
    4. -

      Body of evidence for drug eluting therapies for intermittent claudication

        Michael Dake
    5. -

      Drug coated balloons vs. drug eluting stents in the superficial femoral artery for claudication

    6. -

      Chronic ischaemia below the knee studies – gap in clinical practice evidence

        Iris Baumgartner
    7. -

      Foot care saves legs

        Michael Edmonds
    8. -

      Panel discussion and audience participation

  • Friday, January 25th: - , Discussion Forum

    The optimal treatment approach for highly calcific lesions

    Chairman:
    Michael Jaff
    Discussant:
    Gary Ansel, Lawrence Garcia, Fabrizio Fanelli, Chris Metzger, Patrick Peeters
    1. -

      Crossing highly calcified lesions: This is what works best in my hands

        Gary Ansel
    2. -

      Atherectomy for calcified lesions: Which device works best for which lesion?

        Lawrence Garcia
    3. -

      Is there a role for DEB in calcified arteries?

        Fabrizio Fanelli
    4. -

      A mechanical challenge should be treated mechanically: Interwoven nitinol-stents with high flexibility and radial strength are the solution!

        Chris Metzger
    5. -

      Don’t stretch the limits too far! Surgery is still a good option if endovascular fails.

        Patrick Peeters
    6. -

      Discussion and conclusion

Cookie settings

We use cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operation of the website and to manage our corporate commercial objectives, as well as other cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for the display of personalised content. With the exception of strictly necessary cookies, your are free to decide which categories you would like to permit. Please note that depending on the settings you choose, the full functionality of the website may no longer be available. Further information can be found in our privacy statement and cookie policy.

For more infos on the cookies we use and how you can manage them, please visit our cookie policy.

  • We are using cookies in order to enable the services of the website and to ensure that certain aspects work as required. The cookies within this group are essential for the correct appearance and functionality of the website. No information within these cookies will be given to third parties.

  • We're using functional tracking to analyze the usage of our website. The data hereby gathered, allows us to find errors and improve designs. It also enables us to test the efficacy of our website. These cookies furthermore help us in analyzing our advertisements and affiliate marketing.

  • Our website makes use of external services such as Issuu and Push-Panda. These services provide great value to us and to you as a user. However they do write cookies and collect data about their usage on this website. In order for you to be able to use these services, you will have to give your consent to their respective cookies.